SignatureFD’s Definium Therapeutics DFTX Stock Holding History

SignatureFD’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.52K	Hold	40	–	–	﹤0.01%	3243
2026 Q2	$1.88K	Buy	+40	New	+$988	﹤0.01%	3143
2026 Q1	–	Sell	-2	Closed	-$27	–	3551
2025 Q4	$27	Hold	2	–	–	﹤0.01%	3354
2025 Q3	$24	Hold	2	–	–	﹤0.01%	3349
2025 Q2	$13	Hold	2	–	–	﹤0.01%	3239
2025 Q1	$12	Hold	2	–	–	﹤0.01%	3301
2024 Q4	$14	Hold	2	–	–	﹤0.01%	3282
2024 Q3	$11	Sell	2 -66	-97%	-$459	﹤0.01%	3220
2024 Q2	$490	Hold	68	–	–	﹤0.01%	2990
2024 Q1	$639	Hold	68	–	–	﹤0.01%	3004
2023 Q4	$249	Hold	68	–	–	﹤0.01%	3040
2023 Q3	$213	Buy	68 +66	+3,300%	+$271	﹤0.01%	3088
2023 Q2	$7	Hold	2	–	–	﹤0.01%	3219
2023 Q1	$6	Hold	2	–	–	﹤0.01%	3267
2022 Q4	$4	Sell	2 -2	-50%	-$6	﹤0.01%	3272
2022 Q3	$0	Buy	4 +2	+100%	+$19	﹤0.01%	3256
2022 Q2	$0	Hold	2	–	–	﹤0.01%	3260
2022 Q1	$0	Hold	2	–	–	﹤0.01%	3257
2021 Q4	$0	Hold	2	–	–	﹤0.01%	3205
2021 Q3	$0	Hold	2	–	–	﹤0.01%	3151
2021 Q2	$0	Buy	+2	New	+$105	﹤0.01%	3012

Other funds holding DFTX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

SignatureFD's DFTX Position: Q3 2026 in Review

SignatureFD held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 40 shares worth $1.52K. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

SignatureFD first reported a position in DFTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.88K in Q2 2026. 137 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

SignatureFD held 40 shares of Definium Therapeutics worth $1.52K as of Q3 2026.
SignatureFD left its Definium Therapeutics share count unchanged in Q3 2026.
Definium Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3243 holding.
SignatureFD first reported a position in Definium Therapeutics in Q2 2021 and has held it in 21 quarters since.
SignatureFD's Definium Therapeutics position peaked at $1.88K in Q2 2026.
137 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.